BioCentury
ARTICLE | Company News

Allergene, University of Arizona deal

May 26, 1998 7:00 AM UTC

Allergene acquired exclusive rights from the university to ALG889, a T cell receptor peptide that the company said reverses some immune system abnormalities seen in HIV infection and other immune sys...